Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Sodium Bicarbonate in Preventing Contrast Induced Nephropathy (SIPCIN)

This study has been completed.
Sponsor:
Information provided by:
King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:
NCT00531765
First received: September 17, 2007
Last updated: July 24, 2010
Last verified: July 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2010
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)